nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—Overdose—Capecitabine—colon cancer	0.0357	0.0598	CcSEcCtD
Aminophylline—Acute overdose—Capecitabine—colon cancer	0.0357	0.0598	CcSEcCtD
Aminophylline—HDAC2—Topotecan—Irinotecan—colon cancer	0.0313	1	CbGdCrCtD
Aminophylline—Bronchial hyperreactivity—Methotrexate—colon cancer	0.0138	0.0231	CcSEcCtD
Aminophylline—ADORA2B—smooth muscle tissue—colon cancer	0.0129	0.0694	CbGeAlD
Aminophylline—Inappropriate antidiuretic hormone secretion—Vincristine—colon cancer	0.0128	0.0214	CcSEcCtD
Aminophylline—Chronic obstructive pulmonary disease—Methotrexate—colon cancer	0.0126	0.0211	CcSEcCtD
Aminophylline—Sinus tachycardia—Capecitabine—colon cancer	0.012	0.0201	CcSEcCtD
Aminophylline—HDAC2—embryo—colon cancer	0.0116	0.0626	CbGeAlD
Aminophylline—Abdominal cramps—Vincristine—colon cancer	0.011	0.0184	CcSEcCtD
Aminophylline—Abdominal cramps—Irinotecan—colon cancer	0.0107	0.0179	CcSEcCtD
Aminophylline—Skin necrosis—Methotrexate—colon cancer	0.0103	0.0173	CcSEcCtD
Aminophylline—Heartburn—Fluorouracil—colon cancer	0.0101	0.0168	CcSEcCtD
Aminophylline—PDE3A—smooth muscle tissue—colon cancer	0.00951	0.0511	CbGeAlD
Aminophylline—HDAC2—epithelium—colon cancer	0.0095	0.0511	CbGeAlD
Aminophylline—HDAC2—smooth muscle tissue—colon cancer	0.00916	0.0492	CbGeAlD
Aminophylline—ADORA2B—vagina—colon cancer	0.009	0.0484	CbGeAlD
Aminophylline—Venous thrombosis—Capecitabine—colon cancer	0.00896	0.015	CcSEcCtD
Aminophylline—ADORA1—renal system—colon cancer	0.00892	0.048	CbGeAlD
Aminophylline—HDAC2—renal system—colon cancer	0.00882	0.0474	CbGeAlD
Aminophylline—ADORA2A—lymphoid tissue—colon cancer	0.00858	0.0461	CbGeAlD
Aminophylline—Extravasation—Vincristine—colon cancer	0.0085	0.0142	CcSEcCtD
Aminophylline—Extravasation—Irinotecan—colon cancer	0.00828	0.0139	CcSEcCtD
Aminophylline—Hyperuricaemia—Vincristine—colon cancer	0.008	0.0134	CcSEcCtD
Aminophylline—Extravasation—Fluorouracil—colon cancer	0.00793	0.0133	CcSEcCtD
Aminophylline—Blood uric acid increased—Vincristine—colon cancer	0.00755	0.0127	CcSEcCtD
Aminophylline—Supraventricular tachycardia—Capecitabine—colon cancer	0.00738	0.0124	CcSEcCtD
Aminophylline—HDAC2—lymphoid tissue—colon cancer	0.00732	0.0393	CbGeAlD
Aminophylline—HDAC2—digestive system—colon cancer	0.00723	0.0389	CbGeAlD
Aminophylline—Hypercalcaemia—Capecitabine—colon cancer	0.00696	0.0117	CcSEcCtD
Aminophylline—Haematemesis—Capecitabine—colon cancer	0.00696	0.0117	CcSEcCtD
Aminophylline—Dermatitis contact—Fluorouracil—colon cancer	0.00684	0.0115	CcSEcCtD
Aminophylline—Coma—Vincristine—colon cancer	0.00678	0.0114	CcSEcCtD
Aminophylline—HDAC2—bone marrow—colon cancer	0.00667	0.0358	CbGeAlD
Aminophylline—ADORA1—vagina—colon cancer	0.00646	0.0347	CbGeAlD
Aminophylline—HDAC2—vagina—colon cancer	0.00638	0.0343	CbGeAlD
Aminophylline—Coma—Fluorouracil—colon cancer	0.00632	0.0106	CcSEcCtD
Aminophylline—ADORA2A—liver—colon cancer	0.00632	0.0339	CbGeAlD
Aminophylline—Polyuria—Vincristine—colon cancer	0.00613	0.0103	CcSEcCtD
Aminophylline—Extrasystoles—Capecitabine—colon cancer	0.00575	0.00962	CcSEcCtD
Aminophylline—Disorientation—Fluorouracil—colon cancer	0.00561	0.0094	CcSEcCtD
Aminophylline—PDE3A—liver—colon cancer	0.0056	0.0301	CbGeAlD
Aminophylline—Dermatitis exfoliative—Irinotecan—colon cancer	0.00556	0.00931	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Irinotecan—colon cancer	0.00542	0.00907	CcSEcCtD
Aminophylline—HDAC2—liver—colon cancer	0.00539	0.0289	CbGeAlD
Aminophylline—Ventricular extrasystoles—Capecitabine—colon cancer	0.00535	0.00897	CcSEcCtD
Aminophylline—Gastrooesophageal reflux disease—Capecitabine—colon cancer	0.00535	0.00897	CcSEcCtD
Aminophylline—PDE4A—lymph node—colon cancer	0.00519	0.0279	CbGeAlD
Aminophylline—Haematemesis—Methotrexate—colon cancer	0.00518	0.00868	CcSEcCtD
Aminophylline—Urinary retention—Vincristine—colon cancer	0.00512	0.00858	CcSEcCtD
Aminophylline—Irritability—Fluorouracil—colon cancer	0.00479	0.00803	CcSEcCtD
Aminophylline—Hypokalaemia—Irinotecan—colon cancer	0.00477	0.00799	CcSEcCtD
Aminophylline—Skin exfoliation—Capecitabine—colon cancer	0.00462	0.00773	CcSEcCtD
Aminophylline—PDE3A—lymph node—colon cancer	0.00429	0.0231	CbGeAlD
Aminophylline—ADORA1—lymph node—colon cancer	0.00418	0.0225	CbGeAlD
Aminophylline—HDAC2—lymph node—colon cancer	0.00413	0.0222	CbGeAlD
Aminophylline—Extravasation—Methotrexate—colon cancer	0.00412	0.00691	CcSEcCtD
Aminophylline—Phlebitis—Capecitabine—colon cancer	0.00407	0.00682	CcSEcCtD
Aminophylline—CYP1A2—renal system—colon cancer	0.00405	0.0218	CbGeAlD
Aminophylline—Polyuria—Capecitabine—colon cancer	0.004	0.00669	CcSEcCtD
Aminophylline—Hyperuricaemia—Methotrexate—colon cancer	0.00388	0.0065	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Capecitabine—colon cancer	0.00372	0.00623	CcSEcCtD
Aminophylline—Atrial fibrillation—Capecitabine—colon cancer	0.0037	0.0062	CcSEcCtD
Aminophylline—Blood uric acid increased—Methotrexate—colon cancer	0.00366	0.00614	CcSEcCtD
Aminophylline—CYP2E1—renal system—colon cancer	0.00365	0.0196	CbGeAlD
Aminophylline—Skin exfoliation—Methotrexate—colon cancer	0.00344	0.00576	CcSEcCtD
Aminophylline—Flushing—Irinotecan—colon cancer	0.00337	0.00564	CcSEcCtD
Aminophylline—Irritability—Capecitabine—colon cancer	0.00335	0.00561	CcSEcCtD
Aminophylline—Urinary retention—Capecitabine—colon cancer	0.00334	0.00559	CcSEcCtD
Aminophylline—CYP1A2—digestive system—colon cancer	0.00333	0.0179	CbGeAlD
Aminophylline—Alopecia—Vincristine—colon cancer	0.00329	0.00551	CcSEcCtD
Aminophylline—Coma—Methotrexate—colon cancer	0.00329	0.00551	CcSEcCtD
Aminophylline—Arrhythmia—Irinotecan—colon cancer	0.00324	0.00543	CcSEcCtD
Aminophylline—Alopecia—Irinotecan—colon cancer	0.00321	0.00537	CcSEcCtD
Aminophylline—Abdominal pain upper—Capecitabine—colon cancer	0.00321	0.00537	CcSEcCtD
Aminophylline—Hypokalaemia—Capecitabine—colon cancer	0.00319	0.00535	CcSEcCtD
Aminophylline—Arrhythmia—Fluorouracil—colon cancer	0.0031	0.0052	CcSEcCtD
Aminophylline—Alopecia—Fluorouracil—colon cancer	0.00307	0.00514	CcSEcCtD
Aminophylline—CYP2E1—lymphoid tissue—colon cancer	0.00303	0.0163	CbGeAlD
Aminophylline—CYP2E1—digestive system—colon cancer	0.00299	0.0161	CbGeAlD
Aminophylline—Agitation—Vincristine—colon cancer	0.00298	0.00499	CcSEcCtD
Aminophylline—Polyuria—Methotrexate—colon cancer	0.00298	0.00498	CcSEcCtD
Aminophylline—CYP3A4—renal system—colon cancer	0.00293	0.0158	CbGeAlD
Aminophylline—Convulsion—Vincristine—colon cancer	0.00281	0.00471	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Methotrexate—colon cancer	0.00277	0.00464	CcSEcCtD
Aminophylline—Hyperglycaemia—Capecitabine—colon cancer	0.00274	0.00458	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Methotrexate—colon cancer	0.0027	0.00452	CcSEcCtD
Aminophylline—Anaphylactic shock—Vincristine—colon cancer	0.00265	0.00443	CcSEcCtD
Aminophylline—Infection—Vincristine—colon cancer	0.00263	0.0044	CcSEcCtD
Aminophylline—Convulsion—Fluorouracil—colon cancer	0.00262	0.00439	CcSEcCtD
Aminophylline—Nervous system disorder—Vincristine—colon cancer	0.0026	0.00435	CcSEcCtD
Aminophylline—Haematuria—Capecitabine—colon cancer	0.00258	0.00432	CcSEcCtD
Aminophylline—Anaphylactic shock—Irinotecan—colon cancer	0.00258	0.00432	CcSEcCtD
Aminophylline—Infection—Irinotecan—colon cancer	0.00256	0.00429	CcSEcCtD
Aminophylline—Shock—Irinotecan—colon cancer	0.00254	0.00425	CcSEcCtD
Aminophylline—Nervous system disorder—Irinotecan—colon cancer	0.00253	0.00423	CcSEcCtD
Aminophylline—Anorexia—Vincristine—colon cancer	0.00252	0.00423	CcSEcCtD
Aminophylline—Irritability—Methotrexate—colon cancer	0.00249	0.00418	CcSEcCtD
Aminophylline—CYP1A2—liver—colon cancer	0.00248	0.0133	CbGeAlD
Aminophylline—Hypotension—Vincristine—colon cancer	0.00247	0.00414	CcSEcCtD
Aminophylline—Anaphylactic shock—Fluorouracil—colon cancer	0.00247	0.00413	CcSEcCtD
Aminophylline—Anorexia—Irinotecan—colon cancer	0.00246	0.00411	CcSEcCtD
Aminophylline—Infection—Fluorouracil—colon cancer	0.00245	0.00411	CcSEcCtD
Aminophylline—Nervous system disorder—Fluorouracil—colon cancer	0.00242	0.00405	CcSEcCtD
Aminophylline—Tachycardia—Fluorouracil—colon cancer	0.00241	0.00404	CcSEcCtD
Aminophylline—Hypotension—Irinotecan—colon cancer	0.00241	0.00403	CcSEcCtD
Aminophylline—CYP3A4—digestive system—colon cancer	0.00241	0.0129	CbGeAlD
Aminophylline—Insomnia—Vincristine—colon cancer	0.00239	0.00401	CcSEcCtD
Aminophylline—Anorexia—Fluorouracil—colon cancer	0.00235	0.00394	CcSEcCtD
Aminophylline—Insomnia—Irinotecan—colon cancer	0.00233	0.0039	CcSEcCtD
Aminophylline—Hypotension—Fluorouracil—colon cancer	0.00231	0.00386	CcSEcCtD
Aminophylline—Decreased appetite—Vincristine—colon cancer	0.0023	0.00385	CcSEcCtD
Aminophylline—Dyspepsia—Irinotecan—colon cancer	0.00227	0.0038	CcSEcCtD
Aminophylline—Flushing—Capecitabine—colon cancer	0.00225	0.00377	CcSEcCtD
Aminophylline—Decreased appetite—Irinotecan—colon cancer	0.00224	0.00375	CcSEcCtD
Aminophylline—Insomnia—Fluorouracil—colon cancer	0.00223	0.00374	CcSEcCtD
Aminophylline—CYP2E1—liver—colon cancer	0.00223	0.012	CbGeAlD
Aminophylline—Dyspepsia—Fluorouracil—colon cancer	0.00217	0.00364	CcSEcCtD
Aminophylline—Arrhythmia—Capecitabine—colon cancer	0.00217	0.00363	CcSEcCtD
Aminophylline—Gastrointestinal pain—Vincristine—colon cancer	0.00216	0.00362	CcSEcCtD
Aminophylline—Decreased appetite—Fluorouracil—colon cancer	0.00215	0.00359	CcSEcCtD
Aminophylline—Alopecia—Capecitabine—colon cancer	0.00215	0.00359	CcSEcCtD
Aminophylline—Gastrointestinal pain—Irinotecan—colon cancer	0.00211	0.00353	CcSEcCtD
Aminophylline—Abdominal pain—Vincristine—colon cancer	0.00209	0.0035	CcSEcCtD
Aminophylline—Body temperature increased—Vincristine—colon cancer	0.00209	0.0035	CcSEcCtD
Aminophylline—Abdominal pain—Irinotecan—colon cancer	0.00204	0.00341	CcSEcCtD
Aminophylline—Body temperature increased—Irinotecan—colon cancer	0.00204	0.00341	CcSEcCtD
Aminophylline—Tremor—Capecitabine—colon cancer	0.00198	0.00332	CcSEcCtD
Aminophylline—Urticaria—Fluorouracil—colon cancer	0.00196	0.00328	CcSEcCtD
Aminophylline—Body temperature increased—Fluorouracil—colon cancer	0.00195	0.00327	CcSEcCtD
Aminophylline—Hypersensitivity—Vincristine—colon cancer	0.00195	0.00327	CcSEcCtD
Aminophylline—Haematuria—Methotrexate—colon cancer	0.00192	0.00322	CcSEcCtD
Aminophylline—Hypersensitivity—Irinotecan—colon cancer	0.0019	0.00318	CcSEcCtD
Aminophylline—Palpitations—Capecitabine—colon cancer	0.00187	0.00313	CcSEcCtD
Aminophylline—Hypersensitivity—Fluorouracil—colon cancer	0.00182	0.00305	CcSEcCtD
Aminophylline—Diarrhoea—Vincristine—colon cancer	0.00181	0.00303	CcSEcCtD
Aminophylline—CYP3A4—liver—colon cancer	0.00179	0.00964	CbGeAlD
Aminophylline—Anxiety—Capecitabine—colon cancer	0.00179	0.003	CcSEcCtD
Aminophylline—Diarrhoea—Irinotecan—colon cancer	0.00176	0.00295	CcSEcCtD
Aminophylline—Dizziness—Vincristine—colon cancer	0.00175	0.00293	CcSEcCtD
Aminophylline—Pruritus—Fluorouracil—colon cancer	0.00175	0.00293	CcSEcCtD
Aminophylline—Infection—Capecitabine—colon cancer	0.00171	0.00287	CcSEcCtD
Aminophylline—Dizziness—Irinotecan—colon cancer	0.0017	0.00285	CcSEcCtD
Aminophylline—Shock—Capecitabine—colon cancer	0.0017	0.00284	CcSEcCtD
Aminophylline—Nervous system disorder—Capecitabine—colon cancer	0.00169	0.00283	CcSEcCtD
Aminophylline—Diarrhoea—Fluorouracil—colon cancer	0.00169	0.00283	CcSEcCtD
Aminophylline—Tachycardia—Capecitabine—colon cancer	0.00168	0.00282	CcSEcCtD
Aminophylline—Vomiting—Vincristine—colon cancer	0.00168	0.00282	CcSEcCtD
Aminophylline—Rash—Vincristine—colon cancer	0.00167	0.00279	CcSEcCtD
Aminophylline—Dermatitis—Vincristine—colon cancer	0.00167	0.00279	CcSEcCtD
Aminophylline—Headache—Vincristine—colon cancer	0.00166	0.00278	CcSEcCtD
Aminophylline—Anorexia—Capecitabine—colon cancer	0.00164	0.00275	CcSEcCtD
Aminophylline—Vomiting—Irinotecan—colon cancer	0.00164	0.00274	CcSEcCtD
Aminophylline—Dizziness—Fluorouracil—colon cancer	0.00163	0.00273	CcSEcCtD
Aminophylline—Rash—Irinotecan—colon cancer	0.00162	0.00272	CcSEcCtD
Aminophylline—Dermatitis—Irinotecan—colon cancer	0.00162	0.00272	CcSEcCtD
Aminophylline—Headache—Irinotecan—colon cancer	0.00161	0.0027	CcSEcCtD
Aminophylline—Hypotension—Capecitabine—colon cancer	0.00161	0.0027	CcSEcCtD
Aminophylline—Alopecia—Methotrexate—colon cancer	0.0016	0.00268	CcSEcCtD
Aminophylline—Nausea—Vincristine—colon cancer	0.00157	0.00263	CcSEcCtD
Aminophylline—Vomiting—Fluorouracil—colon cancer	0.00157	0.00263	CcSEcCtD
Aminophylline—Insomnia—Capecitabine—colon cancer	0.00156	0.00261	CcSEcCtD
Aminophylline—Rash—Fluorouracil—colon cancer	0.00156	0.00261	CcSEcCtD
Aminophylline—Dermatitis—Fluorouracil—colon cancer	0.00155	0.0026	CcSEcCtD
Aminophylline—Headache—Fluorouracil—colon cancer	0.00155	0.00259	CcSEcCtD
Aminophylline—Nausea—Irinotecan—colon cancer	0.00153	0.00256	CcSEcCtD
Aminophylline—Dyspepsia—Capecitabine—colon cancer	0.00152	0.00254	CcSEcCtD
Aminophylline—Decreased appetite—Capecitabine—colon cancer	0.0015	0.00251	CcSEcCtD
Aminophylline—Nausea—Fluorouracil—colon cancer	0.00147	0.00246	CcSEcCtD
Aminophylline—Gastrointestinal pain—Capecitabine—colon cancer	0.00141	0.00236	CcSEcCtD
Aminophylline—Urticaria—Capecitabine—colon cancer	0.00137	0.0023	CcSEcCtD
Aminophylline—Abdominal pain—Capecitabine—colon cancer	0.00136	0.00228	CcSEcCtD
Aminophylline—Body temperature increased—Capecitabine—colon cancer	0.00136	0.00228	CcSEcCtD
Aminophylline—Convulsion—Methotrexate—colon cancer	0.00136	0.00228	CcSEcCtD
Aminophylline—Anaphylactic shock—Methotrexate—colon cancer	0.00128	0.00215	CcSEcCtD
Aminophylline—Infection—Methotrexate—colon cancer	0.00128	0.00214	CcSEcCtD
Aminophylline—Hypersensitivity—Capecitabine—colon cancer	0.00127	0.00213	CcSEcCtD
Aminophylline—Nervous system disorder—Methotrexate—colon cancer	0.00126	0.00211	CcSEcCtD
Aminophylline—Anorexia—Methotrexate—colon cancer	0.00122	0.00205	CcSEcCtD
Aminophylline—Pruritus—Capecitabine—colon cancer	0.00122	0.00204	CcSEcCtD
Aminophylline—Hypotension—Methotrexate—colon cancer	0.0012	0.00201	CcSEcCtD
Aminophylline—Diarrhoea—Capecitabine—colon cancer	0.00118	0.00198	CcSEcCtD
Aminophylline—Insomnia—Methotrexate—colon cancer	0.00116	0.00195	CcSEcCtD
Aminophylline—Dizziness—Capecitabine—colon cancer	0.00114	0.00191	CcSEcCtD
Aminophylline—Dyspepsia—Methotrexate—colon cancer	0.00113	0.00189	CcSEcCtD
Aminophylline—Decreased appetite—Methotrexate—colon cancer	0.00112	0.00187	CcSEcCtD
Aminophylline—Vomiting—Capecitabine—colon cancer	0.0011	0.00184	CcSEcCtD
Aminophylline—Rash—Capecitabine—colon cancer	0.00109	0.00182	CcSEcCtD
Aminophylline—Dermatitis—Capecitabine—colon cancer	0.00109	0.00182	CcSEcCtD
Aminophylline—Headache—Capecitabine—colon cancer	0.00108	0.00181	CcSEcCtD
Aminophylline—Gastrointestinal pain—Methotrexate—colon cancer	0.00105	0.00176	CcSEcCtD
Aminophylline—Nausea—Capecitabine—colon cancer	0.00102	0.00172	CcSEcCtD
Aminophylline—Urticaria—Methotrexate—colon cancer	0.00102	0.00171	CcSEcCtD
Aminophylline—Abdominal pain—Methotrexate—colon cancer	0.00102	0.0017	CcSEcCtD
Aminophylline—Body temperature increased—Methotrexate—colon cancer	0.00102	0.0017	CcSEcCtD
Aminophylline—Hypersensitivity—Methotrexate—colon cancer	0.000946	0.00158	CcSEcCtD
Aminophylline—Pruritus—Methotrexate—colon cancer	0.000908	0.00152	CcSEcCtD
Aminophylline—Diarrhoea—Methotrexate—colon cancer	0.000879	0.00147	CcSEcCtD
Aminophylline—Dizziness—Methotrexate—colon cancer	0.000849	0.00142	CcSEcCtD
Aminophylline—Vomiting—Methotrexate—colon cancer	0.000816	0.00137	CcSEcCtD
Aminophylline—Rash—Methotrexate—colon cancer	0.00081	0.00136	CcSEcCtD
Aminophylline—Dermatitis—Methotrexate—colon cancer	0.000809	0.00135	CcSEcCtD
Aminophylline—Headache—Methotrexate—colon cancer	0.000804	0.00135	CcSEcCtD
Aminophylline—Nausea—Methotrexate—colon cancer	0.000763	0.00128	CcSEcCtD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.000298	0.00161	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.000298	0.0016	CbGpPWpGaD
Aminophylline—HDAC2—Circadian rythm related genes—TP53—colon cancer	0.000292	0.00157	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.000292	0.00157	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.000292	0.00157	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—NRAS—colon cancer	0.000288	0.00155	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ODC1—colon cancer	0.000282	0.00152	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CHST5—colon cancer	0.000282	0.00152	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CA7—colon cancer	0.00028	0.00151	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—SRC—colon cancer	0.000278	0.0015	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.000276	0.00148	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	0.000275	0.00148	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—TP53—colon cancer	0.000271	0.00146	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—NRAS—colon cancer	0.000267	0.00144	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—EGFR—colon cancer	0.000262	0.00141	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	0.000254	0.00137	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—KRAS—colon cancer	0.000248	0.00133	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—EP300—colon cancer	0.000244	0.00131	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—EGFR—colon cancer	0.000244	0.00131	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—SRC—colon cancer	0.000237	0.00128	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.000234	0.00126	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—VEGFA—colon cancer	0.000231	0.00124	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—KRAS—colon cancer	0.00023	0.00124	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—NRAS—colon cancer	0.000228	0.00123	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—PIK3CA—colon cancer	0.000227	0.00123	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	0.000225	0.00121	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CA7—colon cancer	0.000216	0.00116	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—TGFB1—colon cancer	0.000212	0.00114	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—PIK3CA—colon cancer	0.000211	0.00114	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—HRAS—colon cancer	0.00021	0.00113	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—KRAS—colon cancer	0.000196	0.00106	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—HRAS—colon cancer	0.000196	0.00105	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—EP300—colon cancer	0.000195	0.00105	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—SRC—colon cancer	0.000189	0.00102	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—AKT1—colon cancer	0.000186	0.001	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—VEGFA—colon cancer	0.000185	0.000994	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—NRAS—colon cancer	0.000182	0.000982	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—PIK3CA—colon cancer	0.00018	0.000971	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—TP53—colon cancer	0.000174	0.00094	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—AKT1—colon cancer	0.000173	0.000931	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CHST5—colon cancer	0.000169	0.000913	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ODC1—colon cancer	0.000169	0.000913	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—TGFB1—colon cancer	0.000169	0.000912	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—HRAS—colon cancer	0.000167	0.000899	CbGpPWpGaD
Aminophylline—HDAC2—Disease—FGFR3—colon cancer	0.000163	0.000876	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—FGFR3—colon cancer	0.000161	0.000869	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—KRAS—colon cancer	0.000157	0.000845	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—PPARG—colon cancer	0.000155	0.000837	CbGpPWpGaD
Aminophylline—HDAC2—Disease—APC—colon cancer	0.000149	0.000805	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—APC—colon cancer	0.000148	0.000798	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—NRAS—colon cancer	0.000148	0.000798	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—AKT1—colon cancer	0.000147	0.000793	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—FGFR3—colon cancer	0.000147	0.000789	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—PIK3CA—colon cancer	0.000144	0.000776	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—FGFR3—colon cancer	0.000143	0.000768	CbGpPWpGaD
Aminophylline—HDAC2—Disease—BRAF—colon cancer	0.00014	0.000756	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—TP53—colon cancer	0.000139	0.000751	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—BRAF—colon cancer	0.000139	0.00075	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—FGFR3—colon cancer	0.000137	0.000739	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—EGFR—colon cancer	0.000135	0.000727	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—APC—colon cancer	0.000135	0.000725	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—NRAS—colon cancer	0.000135	0.000725	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—HRAS—colon cancer	0.000133	0.000718	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—APC—colon cancer	0.000131	0.000705	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—NRAS—colon cancer	0.000131	0.000705	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ODC1—colon cancer	0.000131	0.000705	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CHST5—colon cancer	0.000131	0.000705	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—PIK3CA—colon cancer	0.000129	0.000695	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—KRAS—colon cancer	0.000127	0.000687	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—BRAF—colon cancer	0.000126	0.000681	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—APC—colon cancer	0.000126	0.000679	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—NRAS—colon cancer	0.000126	0.000679	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—BRAF—colon cancer	0.000123	0.000663	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—EGFR—colon cancer	0.000123	0.00066	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—EGFR—colon cancer	0.000119	0.000642	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—BRAF—colon cancer	0.000118	0.000638	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—AKT1—colon cancer	0.000118	0.000634	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—PIK3CA—colon cancer	0.000117	0.000631	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—PIK3CA—colon cancer	0.000117	0.000631	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—KRAS—colon cancer	0.000116	0.000624	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—EGFR—colon cancer	0.000115	0.000618	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—PIK3CA—colon cancer	0.000114	0.000614	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—FGFR3—colon cancer	0.000114	0.000614	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PTGS2—colon cancer	0.000113	0.000611	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—KRAS—colon cancer	0.000113	0.000607	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—PIK3CA—colon cancer	0.00011	0.000591	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—KRAS—colon cancer	0.000108	0.000584	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—HRAS—colon cancer	0.000108	0.000584	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—PIK3CA—colon cancer	0.000106	0.000573	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—FGFR3—colon cancer	0.000106	0.000571	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—AKT1—colon cancer	0.000105	0.000568	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—APC—colon cancer	0.000105	0.000564	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CASP3—colon cancer	0.000104	0.000562	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—PIK3CA—colon cancer	0.000103	0.000557	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCND1—colon cancer	0.000102	0.000547	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CTNNB1—colon cancer	0.000101	0.000547	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CTNNB1—colon cancer	0.000101	0.000542	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—PIK3CA—colon cancer	9.96e-05	0.000537	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CDKN1A—colon cancer	9.91e-05	0.000534	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—HRAS—colon cancer	9.84e-05	0.00053	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—BRAF—colon cancer	9.83e-05	0.00053	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CDKN1A—colon cancer	9.83e-05	0.00053	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—APC—colon cancer	9.72e-05	0.000524	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—NRAS—colon cancer	9.72e-05	0.000524	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—HRAS—colon cancer	9.57e-05	0.000516	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—AKT1—colon cancer	9.57e-05	0.000515	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—AKT1—colon cancer	9.57e-05	0.000515	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CASP3—colon cancer	9.48e-05	0.000511	CbGpPWpGaD
Aminophylline—HDAC2—Disease—EP300—colon cancer	9.43e-05	0.000508	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—EP300—colon cancer	9.35e-05	0.000504	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—AKT1—colon cancer	9.31e-05	0.000501	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCND1—colon cancer	9.23e-05	0.000497	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CASP3—colon cancer	9.22e-05	0.000497	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—HRAS—colon cancer	9.21e-05	0.000496	CbGpPWpGaD
Aminophylline—HDAC2—Disease—SRC—colon cancer	9.17e-05	0.000494	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—BRAF—colon cancer	9.14e-05	0.000492	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CTNNB1—colon cancer	9.14e-05	0.000492	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—SRC—colon cancer	9.1e-05	0.00049	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCND1—colon cancer	8.98e-05	0.000484	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—AKT1—colon cancer	8.96e-05	0.000483	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CDKN1A—colon cancer	8.93e-05	0.000481	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CTNNB1—colon cancer	8.89e-05	0.000479	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CASP3—colon cancer	8.88e-05	0.000478	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—EGFR—colon cancer	8.86e-05	0.000477	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—VEGFA—colon cancer	8.86e-05	0.000477	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—MYC—colon cancer	8.85e-05	0.000477	CbGpPWpGaD
Aminophylline—HDAC2—Disease—NRAS—colon cancer	8.82e-05	0.000475	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—NRAS—colon cancer	8.75e-05	0.000471	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—AKT1—colon cancer	8.69e-05	0.000468	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CDKN1A—colon cancer	8.68e-05	0.000468	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCND1—colon cancer	8.64e-05	0.000465	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CTNNB1—colon cancer	8.56e-05	0.000461	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—EP300—colon cancer	8.49e-05	0.000458	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—PIK3CA—colon cancer	8.47e-05	0.000456	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—AKT1—colon cancer	8.45e-05	0.000455	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—KRAS—colon cancer	8.37e-05	0.000451	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CDKN1A—colon cancer	8.36e-05	0.00045	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—EP300—colon cancer	8.26e-05	0.000445	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SRC—colon cancer	8.26e-05	0.000445	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MYC—colon cancer	8.22e-05	0.000443	CbGpPWpGaD
Aminophylline—HDAC2—Disease—TGFB1—colon cancer	8.2e-05	0.000442	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MYC—colon cancer	8.15e-05	0.000439	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—AKT1—colon cancer	8.14e-05	0.000438	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TGFB1—colon cancer	8.13e-05	0.000438	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—VEGFA—colon cancer	8.04e-05	0.000433	CbGpPWpGaD
Aminophylline—HDAC2—Disease—EGFR—colon cancer	8.04e-05	0.000433	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SRC—colon cancer	8.03e-05	0.000433	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—EGFR—colon cancer	7.97e-05	0.000429	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EP300—colon cancer	7.95e-05	0.000428	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—NRAS—colon cancer	7.95e-05	0.000428	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—VEGFA—colon cancer	7.83e-05	0.000422	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SRC—colon cancer	7.73e-05	0.000417	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—NRAS—colon cancer	7.73e-05	0.000416	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—PIK3CA—colon cancer	7.69e-05	0.000414	CbGpPWpGaD
Aminophylline—HDAC2—Disease—KRAS—colon cancer	7.59e-05	0.000409	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—VEGFA—colon cancer	7.53e-05	0.000406	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—KRAS—colon cancer	7.53e-05	0.000406	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ABCB1—colon cancer	7.45e-05	0.000401	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NRAS—colon cancer	7.44e-05	0.000401	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MYC—colon cancer	7.4e-05	0.000399	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TGFB1—colon cancer	7.38e-05	0.000398	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CASP3—colon cancer	7.37e-05	0.000397	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—TYMS—colon cancer	7.32e-05	0.000394	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—EGFR—colon cancer	7.24e-05	0.00039	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MYC—colon cancer	7.2e-05	0.000388	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TGFB1—colon cancer	7.18e-05	0.000387	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCND1—colon cancer	7.18e-05	0.000387	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—HRAS—colon cancer	7.11e-05	0.000383	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CTNNB1—colon cancer	7.11e-05	0.000383	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—EGFR—colon cancer	7.04e-05	0.000379	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7e-05	0.000377	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PIK3CA—colon cancer	6.98e-05	0.000376	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CDKN1A—colon cancer	6.94e-05	0.000374	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MYC—colon cancer	6.93e-05	0.000373	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PIK3CA—colon cancer	6.92e-05	0.000373	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—AKT1—colon cancer	6.92e-05	0.000373	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TGFB1—colon cancer	6.91e-05	0.000372	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CASP3—colon cancer	6.85e-05	0.000369	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—KRAS—colon cancer	6.84e-05	0.000368	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EGFR—colon cancer	6.78e-05	0.000365	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TP53—colon cancer	6.69e-05	0.000361	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCND1—colon cancer	6.67e-05	0.000359	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KRAS—colon cancer	6.65e-05	0.000358	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CTNNB1—colon cancer	6.61e-05	0.000356	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EP300—colon cancer	6.61e-05	0.000356	CbGpPWpGaD
Aminophylline—HDAC2—Disease—HRAS—colon cancer	6.46e-05	0.000348	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CDKN1A—colon cancer	6.45e-05	0.000348	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SRC—colon cancer	6.42e-05	0.000346	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KRAS—colon cancer	6.4e-05	0.000345	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—HRAS—colon cancer	6.4e-05	0.000345	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PIK3CA—colon cancer	6.28e-05	0.000338	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—AKT1—colon cancer	6.28e-05	0.000338	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—VEGFA—colon cancer	6.26e-05	0.000337	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NRAS—colon cancer	6.18e-05	0.000333	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EP300—colon cancer	6.14e-05	0.000331	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—AKT1—colon cancer	6.14e-05	0.000331	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PIK3CA—colon cancer	6.11e-05	0.000329	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TP53—colon cancer	6.08e-05	0.000327	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SRC—colon cancer	5.97e-05	0.000322	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TP53—colon cancer	5.91e-05	0.000319	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PIK3CA—colon cancer	5.88e-05	0.000317	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—VEGFA—colon cancer	5.82e-05	0.000313	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—HRAS—colon cancer	5.81e-05	0.000313	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MYC—colon cancer	5.76e-05	0.00031	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NRAS—colon cancer	5.74e-05	0.000309	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TGFB1—colon cancer	5.74e-05	0.000309	CbGpPWpGaD
Aminophylline—HDAC2—Disease—AKT1—colon cancer	5.7e-05	0.000307	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TP53—colon cancer	5.69e-05	0.000307	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—HRAS—colon cancer	5.65e-05	0.000305	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—AKT1—colon cancer	5.65e-05	0.000305	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EGFR—colon cancer	5.63e-05	0.000303	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.5e-05	0.000296	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—HRAS—colon cancer	5.44e-05	0.000293	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MYC—colon cancer	5.35e-05	0.000288	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TGFB1—colon cancer	5.34e-05	0.000288	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KRAS—colon cancer	5.32e-05	0.000287	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EGFR—colon cancer	5.23e-05	0.000282	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PPARG—colon cancer	5.18e-05	0.000279	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—AKT1—colon cancer	5.13e-05	0.000277	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—AKT1—colon cancer	4.99e-05	0.000269	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KRAS—colon cancer	4.94e-05	0.000266	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3CA—colon cancer	4.89e-05	0.000263	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—AKT1—colon cancer	4.81e-05	0.000259	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TP53—colon cancer	4.73e-05	0.000255	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.58e-05	0.000247	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CA—colon cancer	4.54e-05	0.000245	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—HRAS—colon cancer	4.52e-05	0.000244	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ABCB1—colon cancer	4.48e-05	0.000241	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—TYMS—colon cancer	4.4e-05	0.000237	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TP53—colon cancer	4.39e-05	0.000237	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—HRAS—colon cancer	4.2e-05	0.000226	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS2—colon cancer	4.08e-05	0.00022	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—AKT1—colon cancer	3.99e-05	0.000215	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—AKT1—colon cancer	3.71e-05	0.0002	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCB1—colon cancer	3.46e-05	0.000186	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—TYMS—colon cancer	3.39e-05	0.000183	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—EP300—colon cancer	3.39e-05	0.000183	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.39e-05	0.000182	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PPARG—colon cancer	3.12e-05	0.000168	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CA—colon cancer	2.51e-05	0.000135	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS2—colon cancer	2.45e-05	0.000132	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PPARG—colon cancer	2.4e-05	0.00013	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—AKT1—colon cancer	2.05e-05	0.00011	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—EP300—colon cancer	2.04e-05	0.00011	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS2—colon cancer	1.89e-05	0.000102	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—EP300—colon cancer	1.57e-05	8.47e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CA—colon cancer	1.51e-05	8.12e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—AKT1—colon cancer	1.23e-05	6.64e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CA—colon cancer	1.16e-05	6.27e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—AKT1—colon cancer	9.51e-06	5.12e-05	CbGpPWpGaD
